Inotir
Commercial- Indications
- Nutritional supplementation
Company intelligence / Profile preview
Pharmarte is an Italian healthcare company focused on pharmaceutical, nutraceutical, and food-for-special-medical-purpose products rather than a traditional clinical-stage biotech pipeline. The company markets nutritional support products in areas including female reproductive health, homocysteine metabolism linked to MTHFR-associated defects, and antioxidant/neurovascular support. Its portfolio includes brands such as INOMEL, Semel, Semel Oro, MTHFR Prevent, and MTHFR Prevent Plus. Pharmarte states that it distributes across Italy and has international presence in markets including Vietnam, Uzbekistan, Kazakhstan, and Jordan. Based on available public information, the business appears to be a commercial-stage specialty health products company with limited evidence of proprietary drug candidates in formal clinical development.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmarte.